Shigeyuki Tamura

Summary

Affiliation: Kansai Rosai Hospital
Country: Japan

Publications

  1. pmc Lymph node dissection in curative gastrectomy for advanced gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, 1 69 3 Chome, Inabasou, Amagasaki, Hyogo 660 8511, Japan
    Int J Surg Oncol 2011:748745. 2011
  2. ncbi request reprint Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403)
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Hyogo, Japan
    Anticancer Res 32:1403-8. 2012
  3. doi request reprint Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, 660 8511, Japan
    Int J Clin Oncol 13:536-40. 2008
  4. ncbi request reprint Mucoepidermoid carcinoma of the esophagus treated by endoscopic mucosal resection
    S Tamura
    Department of Surgery, Kinki Central Hospital of the Mutual Aid Association of Public School Teachers, Itami, Japan
    Dis Esophagus 16:265-7. 2003
  5. doi request reprint Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan
    Oncology 80:296-300. 2011
  6. doi request reprint Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, 660 8511, Japan
    Gastric Cancer 13:101-8. 2010
  7. ncbi request reprint The novel germline mutation of the hMLH1 gene in a case of suspected hereditary non-polyposis colorectal cancer (HNPCC) in a patient with no family history of cancer
    Naohiro Tomita
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo 660 8511, Japan
    Jpn J Clin Oncol 34:556-60. 2004
  8. ncbi request reprint Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, 3 1 69 Inabaso, Amagasaki, 660 8511, Japan
    Gastric Cancer 10:251-5. 2007
  9. ncbi request reprint [Two cases of lower bile duct recurrence resected by pancreatoduodenectomy after hepatectomy for hilar cholangiocarcinoma]
    Shin Nakahira
    Dept of Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 39:2119-21. 2012
  10. ncbi request reprint [A case of gastric cancer with liver metastasis had a good reaction to S-1/CDDP chemotherapy after S-1 chemotherapy was ineffective]
    Kumiko Uji
    Department of Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 38:1691-4. 2011

Collaborators

Detail Information

Publications24

  1. pmc Lymph node dissection in curative gastrectomy for advanced gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, 1 69 3 Chome, Inabasou, Amagasaki, Hyogo 660 8511, Japan
    Int J Surg Oncol 2011:748745. 2011
    ..In this paper, we present an update on the current literature regarding the extent of lymphadenectomy for advanced gastric cancer...
  2. ncbi request reprint Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403)
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Hyogo, Japan
    Anticancer Res 32:1403-8. 2012
    ....
  3. doi request reprint Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, 660 8511, Japan
    Int J Clin Oncol 13:536-40. 2008
    ..There is no standard treatment for peritoneal dissemination from gastric cancer. A novel combination chemotherapy has been introduced for patients with advanced gastric cancer with peritoneal metastasis...
  4. ncbi request reprint Mucoepidermoid carcinoma of the esophagus treated by endoscopic mucosal resection
    S Tamura
    Department of Surgery, Kinki Central Hospital of the Mutual Aid Association of Public School Teachers, Itami, Japan
    Dis Esophagus 16:265-7. 2003
    ..Radiation therapy with a total dose of 60 Gy was performed and there has been no recurrence or metastasis to other organs during 36 months of follow-up...
  5. doi request reprint Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan
    Oncology 80:296-300. 2011
    ..The aim of this prospective study was to evaluate the feasibility and safety of adjuvant S-1 plus docetaxel in patients with stage III gastric cancer...
  6. doi request reprint Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, 660 8511, Japan
    Gastric Cancer 13:101-8. 2010
    ..This pilot study was carried out to evaluate the efficacy of chemotherapy for patients with peritoneal dissemination from gastric cancer or positive lavage cytology diagnosed by staging laparoscopy...
  7. ncbi request reprint The novel germline mutation of the hMLH1 gene in a case of suspected hereditary non-polyposis colorectal cancer (HNPCC) in a patient with no family history of cancer
    Naohiro Tomita
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo 660 8511, Japan
    Jpn J Clin Oncol 34:556-60. 2004
    ..According to the Human Mutation Database and International Collaborative Group on HNPCC (ICG-HNPCC) Database, this is the first report of this type of deletion mutation in the hMLH1 gene...
  8. ncbi request reprint Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital, 3 1 69 Inabaso, Amagasaki, 660 8511, Japan
    Gastric Cancer 10:251-5. 2007
    ..This chemotherapy can be applied as one of the promising candidates for the treatment of patients with peritoneal metastasis of gastric cancer...
  9. ncbi request reprint [Two cases of lower bile duct recurrence resected by pancreatoduodenectomy after hepatectomy for hilar cholangiocarcinoma]
    Shin Nakahira
    Dept of Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 39:2119-21. 2012
    ..The patient died of local recurrence 6 months after the secondary operation...
  10. ncbi request reprint [A case of gastric cancer with liver metastasis had a good reaction to S-1/CDDP chemotherapy after S-1 chemotherapy was ineffective]
    Kumiko Uji
    Department of Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 38:1691-4. 2011
    ..The patient is still alive, maintaining the effect of PR for 17 months without any adverse effects except appetite loss and vomiting of grade 2...
  11. ncbi request reprint [Outcome of therapy for type 4 gastric cancer with peritoneal metastasis--diagnosis by laparoscopy and effect of chemotherapy]
    Shigeyuki Tamura
    Department of Surgery, Kansai Rosai Hospital
    Gan To Kagaku Ryoho 36:2000-2. 2009
    ..Laparoscopy (st-lap) was performed for type 4 advanced gastric cancer cases, and chemotherapy was performed for P1 or CY1[ P(+)] cases. We present the results here...
  12. doi request reprint Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study
    Kazumasa Fujitani
    Department of Surgery, Osaka National Hospital, Hoenzaka 2 1 14, Chuo Ku, Osaka, 540 0006, Japan
    Gastric Cancer 16:301-8. 2013
    ..We identified the pattern of abdominal nodal spread in advanced type II adenocarcinoma and defined the optimal extent of abdominal lymphadenectomy...
  13. doi request reprint Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trial
    Shigeyuki Tamura
    Department of Gastroenterological Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan
    J Surg Oncol 109:75-80. 2014
    ..The purpose of this study is to define the clinical significance of the molecular analysis of peritoneal lavage fluid in patients with gastric cancer in a multicenter prospective trial...
  14. ncbi request reprint [A case of advanced cholangiolocellular carcinoma successfully treated by neoadjuvant chemotherapy with gemcitabine followed by radical resection]
    Hiroshi Kawashima
    Dept of Gastroenterological Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 39:2113-5. 2012
    ..Therapy for cholangiolocellular carcinoma has not yet been established, but multimodal treatment with GEM and surgical resection is potentially effective for cholangiolocellular carcinoma...
  15. ncbi request reprint [A case of primary neuroendocrine carcinoma of the bile duct]
    Michiko Hamanaka
    Dept of Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 39:2125-7. 2012
    ..Although TACE exerted a cytoreductive effect temporarily, multiple liver abscesses developed. The patient died of liver failure 16 months after the operation. We report this rare case of primary neuroendocrine carcinoma of the bile duct...
  16. doi request reprint Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
    Kazumasa Fujitani
    Department of Surgery, Osaka National Hospital, 2 1 14 Hoenzaka, Chuo Ku, Osaka, 540 0006, Japan
    Gastric Cancer 17:348-53. 2014
    ..We report 3-year follow-up data on patients enrolled in this study...
  17. pmc Immunohistochemical consistency between primary tumors and lymph node metastases of gastric neuroendocrine carcinoma
    Chieko Uchiyama
    Department of Surgery, Kansai Rousai Hospital, 3 1 69 Inabaso, Amagasaki City, Hyogo 660 8511, Japan
    World J Surg Oncol 10:115. 2012
    ..We studied the clinicopathological findings of seven patients at our institute to better under this disease...
  18. ncbi request reprint [Analysis of breast reconstruction with a tissue expander and implant after ipsilateral breast tumor recurrence in patients undergoing breast-conserving surgery]
    Masatsugu Okishiro
    Dept of Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 39:2030-2. 2012
    ..However, with appropriate explanation of the risks, this surgery is an option for patients who strongly desire breast reconstruction...
  19. ncbi request reprint [A case of successful treatment with intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombus]
    Yosuke Mukai
    Dept of Surgery, Kansai Rosai Hospital, Japan
    Gan To Kagaku Ryoho 39:1815-8. 2012
    ..He has been alive for more than 1 year without recurrence. CDDP is an effective treatment for advanced HCC with portal vein tumor thrombus...
  20. doi request reprint Clinical outcome and indications for palliative gastrojejunostomy in unresectable advanced gastric cancer: multi-institutional retrospective analysis
    Atsushi Takeno
    Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan
    Ann Surg Oncol 20:3527-33. 2013
    ..In this multi-institutions study, we investigated the clinical outcome of GJJ for UAGC and predictors of outcome and survival...
  21. doi request reprint Chyluria after ligation of the thoracic duct: a rare complication after thoracoscopic-assisted esophagectomy for esophageal cancer
    Atsushi Takeno
    Department of Surgery, Kansai Rosai Hospital, 3 1 69, Inabasou, Amagasaki, Hyogo, 660 8511, Japan
    Surg Today 44:757-60. 2014
    ..He underwent esophageal reconstruction with a gastric tube through an anterior mediastinal route, and was discharged 36 days after the second operation. He was thereafter followed up at the outpatient clinic with radiotherapy...
  22. ncbi request reprint The novel germline mutation of hMSH2 gene in a case of a hereditary non-polyposis colorectal cancer (HNPCC) patient who meets the revised Amsterdam criteria
    Naohiro Tomita
    Department of Surgery, Kansai Rosai Hospital, 3 1 69 Inaba so, Amagasaki, Hyogo 660 8511, Japan
    Jpn J Clin Oncol 33:486-9. 2003
    ..According to the Human Mutation Database and International Collaborative Group on HNPCC (ICG-HNPCC) Database, this type of nonsense mutation is the first report in the hMSH2 gene...
  23. ncbi request reprint Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer
    H Shiozaki
    Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
    Dis Esophagus 14:191-6. 2001
    ..In conclusion, cervical lymphadenectomy can be omitted for recurrent nerve chain node-negative patients with middle and lower thoracic esophageal cancer...
  24. pmc Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus
    K Nishioka
    Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, 2 2 E2, Yamadaoka Suita, Osaka, 565 0871, Japan
    Br J Cancer 85:412-21. 2001
    ..Thus, regulation of the G1 checkpoint in the cell cycle may be important in oesophageal carcinogenesis, which may also involve many other oncogenes...